Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.19.3
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Amortized cost of securities available for sale $ 616,604 $ 583,444
Allowance for loan losses of loans receivable $ 50,712 $ 31,974
Preferred stock par value (in usd per share) $ 0.001 $ 0.001
Preferred stock authorized (shares) 10,000,000 10,000,000
Preferred stock issued (shares) 0 0
Common stock par value (in usd per share) $ 0.001 $ 0.001
Common stock authorized (shares) 62,500,000 62,500,000
Common stock issued (shares) 33,471,702 33,202,369
Common stock outstanding (shares) 31,173,881 30,928,437
Accumulated other comprehensive loss, tax (expense) benefit $ (1,500) $ 2,457
Treasury stock (shares) 2,297,821 2,273,932